Reference no: EM131501188

1. What are the frequency and percentage of the COPD patients in the severe airflow limitation group who are employed in the Eckerblad et al. (2014) study?

2. What percentage of the total sample is retired? What percentage of the total sample is on sick leave?

3. What is the total sample size of this study? What frequency and percentage of the total sample were still employed? Show your calculations and round your answer to the nearest whole percent.

4. What is the total percentage of the sample with a smoking history-either still smoking or former smokers? Is the smoking history for study participants clinically important? Provide a rationale for your answer.

5. What are pack years of smoking? Is there a significant difference between the moderate and severe airflow limitation groups regarding pack years of smoking? Provide a rationale for your answer.

6. What were the four most common psychological symptoms reported by this sample of patients with COPD? What percentage of these subjects experienced these symptoms? Was there a significant difference between the moderate and severe airflow limitation groups for psychological symptoms?

7. What frequency and percentage of the total sample used short-acting β₂-agonists? Show your calculations and round to the nearest whole percent.

8. Is there a significant difference between the moderate and severe airflow limitation groups regarding the use of short-acting β₂-agonists? Provide a rationale for your answer.

9. Was the percentage of COPD patients with moderate and severe airflow limitation using short-acting β₂-agonists what you expected? Provide a rationale with documentation for your answer.

10. Are these findings ready for use in practice? Provide a rationale for your answer.